Search Results

Search Results for "diabetes"

• Diabetes drug works in late-stage trials
  Pharmaceutical companies Eli Lilly and Co and Boehringer Ingelheim announced that their type 2 diabetes treatment, empagliflozin, has been shown to work in four late-stage trials. According to a Reuters report, the companies expect to file for regulatory review of the drug in the United States, Euro...

• Diabetes drug creates risk for kidney problems
  A report in Health Magazine says the type 2 diabetes drug Byetta could put patients at risk for kidney problems, including kidney failure. According to the report, Byetta is a relatively new drug that’s proven popular because it can promote weight loss and it’s easier to inject than insulin. But...

• Diabetes drug looks good in study
  The blog FiercePharma reports that the diabetes drug Victoza has performed well in a clinical study – performing better than competitors Januvia and Byetta in keeping patients’ blood sugar below a target of 7 percent. Novo Nordisk, Victoza’s manufacturer, is working to secure more of an edge i...

• Company conducting trial on new diabetes drug
  Poxel SA, a France-based company spun off from the pharmaceutical division of Merck, has raised $17.1 million in venture backing to fund a clinical trial for an experimental Type 2 diabetes drug, Bloomberg reports. According to Bloomberg, the compound imeglimin is part of a new class of oral anti-di...

• Additional warnings for diabetes drug
  A story by ABC News reports on the U.S. Food and Drug Administration’s changes to prescribing information for the diabetes drug Byetta, in response to reports about kidney problems. According to the story, the FDA received 78 reports of kidney function problems from patients taking Byetta between ...

• Increasing rate of eyesight loss may be from diabetes
  A new study says an increasing number of Americans are losing their eyesight, which may be a result of diabetes. CBS News cites research concluding that from 1999 through 2002, about 1.4 percent of Americans had visual impairment. That percentage rose to 1.7 percent between 2005 and 2008, representi...

• European regulators approve diabetes drug
  The European Commission has approved a diabetes medicine that U.S. regulators have rejected, Reuters reports. The medication, by Bristol-Myers Squibb Co and AstraZeneca Plc, is called Forxiga. It’s part of a new class of diabetes drugs that work independently of insulin to control blood sugar. Its...

• Study: Diabetes drugs no better than cheaper alternatives
  A Bloomberg story says two relatively new diabetes medicines – Merck’s Januvia and Eli Lilly’s Byetta – don’t work any better than less expensive drugs that were already on the market. A month’s supply of Januvia costs $163.99, or almost $5.50 a pill, Bloomberg says. And a single car...

• Group calls for banning diabetes drug
  Nonprofit consumer advocacy group Public Citizen has submitted a petition to the U.S. Food and Drug Administration, calling for a diabetes drug to be banned in light of studies linking the it to pancreatic and thyroid cancer. According to a story about the issue in the journal Nature, a patient stan...

• FDA considers stronger warning for diabetes drug
  A story in the New York Times concerns efforts by federal regulators to develop a stronger label for the diabetes drug Byetta, manufactured by Eli Lilly, following more reports of deadly pancreatitis. The U.S. Food and Drug Administration reported an additional six cases of pancreatitis. Two of the ...